The effect of high amylose wheat on fecal butyrate and total short-chain fatty acids levels in healthy Australian men and women

Arista Cereal Technologies0 个研究点目标入组 80 人开始时间: 2018年6月26日最近更新: 2019年7月15日

适应症

试验速览

暂无简介。

•Healthy adult male or female, aged 18-80 years.
•BMI 18.5-29.9 kg/m2.
•Understand the study requirements, including faecal collections and willing to adhere closely to prescribed food consumption as per the research protocol.
•Willing to maintain body weight for the duration of the study (i.e. no more than 3 kg weight loss/gain).

•EXCLUSION CRITERIA
•Received any medication or undergone surgery that in the opinion of the Principal Investigator or designee could interfere with the study and likely to modulate gut function.
•Self-reported history of alcohol or drug abuse.
•Self-reported participation in a study with any experimental drug within 30 days of commencement of the study.
•Self-reported history of diabetes, gastrointestinal, renal, hepatic disease or intestinal inflammation, including inflammatory bowel disease (Crohn’s disease and ulcerative colitis), coeliac disease, irritable bowel syndrome, chronic constipation or regular bouts of diarrhoea.
•Use of any form of medication/nutraceutical that may interfere with bowel function (such as antibiotics, laxatives, fibre supplements consumed on a regular basis).
•Known or suspected allergy, hypersensitivity or intolerance to consumption of plant-based foods which will be tested in this study.
•Night shift worker
•History of smoking within the 6 months prior to the study
•Self-reported pregnant or currently lactating women
•Extended absences due to travel or other commitments

发起方

Arista Cereal Technologies